These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Novel thiazolidine-2,4-diones as potent euglycemic agents. Hulin B; Clark DA; Goldstein SW; McDermott RE; Dambek PJ; Kappeler WH; Lamphere CH; Lewis DM; Rizzi JP J Med Chem; 1992 May; 35(10):1853-64. PubMed ID: 1588563 [TBL] [Abstract][Full Text] [Related]
11. (3-substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents. Nomura M; Kinoshita S; Satoh H; Maeda T; Murakami K; Tsunoda M; Miyachi H; Awano K Bioorg Med Chem Lett; 1999 Feb; 9(4):533-8. PubMed ID: 10098657 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and hypoglycemic activity of some substituted flavonyl thiazolidinedione derivatives--fifth communication: flavonyl benzyl substituted 2,4-thiazolidinediones. Tunçbilek M; Bozdağ-Dündar O; Ayhan-Kilcigil G; Ceylan M; Waheed A; Verspohl EJ; Ertan R Farmaco; 2003 Jan; 58(1):79-83. PubMed ID: 12595040 [TBL] [Abstract][Full Text] [Related]
13. Novel 5-(3-aryl-2-propynyl)-5-(arylsulfonyl)thiazolidine-2,4-diones as antihyperglycemic agents. Wrobel J; Li Z; Dietrich A; McCaleb M; Mihan B; Sredy J; Sullivan D J Med Chem; 1998 Mar; 41(7):1084-91. PubMed ID: 9544208 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of 3-substituted phenacyl-5-[2-phenyl-4H-4-oxo-1-benzopyran-6- yl)methylenyl]-thiazolidine-2,4-diones and evaluation of their antimicrobial activity. Ayhan-Kilcigil G; Altanlar N Arzneimittelforschung; 2000 Feb; 50(2):154-7. PubMed ID: 10719619 [TBL] [Abstract][Full Text] [Related]
15. Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents. Clark DA; Goldstein SW; Volkmann RA; Eggler JF; Holland GF; Hulin B; Stevenson RW; Kreutter DK; Gibbs EM; Krupp MN J Med Chem; 1991 Jan; 34(1):319-25. PubMed ID: 1992133 [TBL] [Abstract][Full Text] [Related]
16. [Synthesis and antimicrobial activity of chlorobenzyl benzylidene imidazolidinedione derivatives and substituted thiazolidinediones]. Lima MC; Costa DL; Goes AJ; Galdino SL; Pitta IR; Luu-Duc C Pharmazie; 1992 Mar; 47(3):182-4. PubMed ID: 1615023 [TBL] [Abstract][Full Text] [Related]
17. A convenient approach to synthesize substituted 5-Arylidene-3-m-tolyl thiazolidine-2, 4-diones by using morpholine as a catalyst and its theoretical study. Jahan K; Khan KR; Akhter K; Romman UKR; Halim E PLoS One; 2021; 16(3):e0247619. PubMed ID: 33661961 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and antimicrobial activity of substituted imidazolidinediones and thioxoimidazolidinones. Albuquerque JF; Rocha Filho JA; Brandao SS; Lima MC; Ximenes EA; Galdino SL; Pitta IR; Chantegrel J; Perrissin M; Luu-Duc C Farmaco; 1999; 54(1-2):77-82. PubMed ID: 10321032 [TBL] [Abstract][Full Text] [Related]
19. Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators. Vu CB; Bemis JE; Disch JS; Ng PY; Nunes JJ; Milne JC; Carney DP; Lynch AV; Smith JJ; Lavu S; Lambert PD; Gagne DJ; Jirousek MR; Schenk S; Olefsky JM; Perni RB J Med Chem; 2009 Mar; 52(5):1275-83. PubMed ID: 19199480 [TBL] [Abstract][Full Text] [Related]
20. Studies on antidiabetic agents. II. Synthesis of 5-[4-(1-methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and its derivatives. Sohda T; Mizuno K; Imamiya E; Sugiyama Y; Fujita T; Kawamatsu Y Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3580-600. PubMed ID: 7160012 [No Abstract] [Full Text] [Related] [Next] [New Search]